Acute pain after thoracoscopic surgery
Conditions
Interventions
Group A: Oseley set group:Oxalidine 30mg + 70ml saline 100ml, the first dose 1.5mg (5ml), PCA 0.35mg (1.2ml), interval 6min, no background measurement, the maximum dose was 70ml/ days.
Group B: Sufentanil group:sufentanil 100ug + 100ml saline 100ml, first dose 5ug (5ml), PCA 1.2ug (1.2ml), interval 6min.
Sponsors
Shanghai Fourth People's Hospital affiliated to Tongji University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. The age ranges from 18 to 75 years old, regardless of sex. 2. Thoracoscopic surgery is planned. Patients who need patient-controlled intravenous analgesia after operation. 3. ASA I-III level; 4. Voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Chronic pain, long-term use of analgesics, psychiatric drugs (including opioids, NSAIDs, sedation, antidepressants), alcohol abuse; 2. Allergic to research drugs; 3. BMI& gt;40kg/m2 or BMI<20kg/m2; 4. Patients who are unable to cooperate with shock and mental disorders; 5. Have severe heart or liver disease; 6. Acute and chronic bronchial asthma; 7. Suspected gastrointestinal obstruction; 8. A pregnant woman or pregnant woman. 9. Sleep apnea; 10. Participated in other drug trials in three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity within 24 hours after operation (using visual analogue scale, VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Total consumption of analgesics;Incidence of side effects (e.g. nausea, vomiting, respiratory depression: respiratory rate & lt;8 / min or finger pulse oxygen saturation<90%);Hospitalization time;Patient satisfaction;Postoperative ICU stay time; | — |
Countries
CHINA
Contacts
Public ContactTan Jingjing
Department of Anesthesia and Perioperative Medicine
Outcome results
None listed